http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 03 Jun 2026 05:13:02 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR230+at+HSBC/26594519.html HSBC analyst Shubhangi Gupta lowered the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR230.00 (from EUR233.00) while maintaining a Buy rating. http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR230+at+HSBC/26594519.html Wed, 03 Jun 2026 05:13:02 -0400 SDMHF http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR230+at+HSBC/26594519.html HSBC analyst Shubhangi Gupta lowered the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR230.00 (from EUR233.00) while maintaining a Buy rating. http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR230+at+HSBC/26594519.html Wed, 03 Jun 2026 05:13:02 -0400 SDMHF http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR230+at+HSBC/26594519.html HSBC analyst Shubhangi Gupta lowered the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR230.00 (from EUR233.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR230+at+HSBC/26594519.html Wed, 03 Jun 2026 05:13:02 -0400 SDMHF http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR230+at+HSBC/26594519.html HSBC analyst Shubhangi Gupta lowered the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR230.00 (from EUR233.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR230+at+HSBC/26594519.html Wed, 03 Jun 2026 05:13:02 -0400 SDMHF http://www.streetinsider.com/SEC+Filings/Form++F-6EF++++++Sartorius+Stedim+Biotech+++++++++++++++Filed+by%3A+BANK+OF+NEW+YORK++ADR+DIVISION/26351097.html si-local-file:///var/storage/secattach/20260422/26351097.html http://www.streetinsider.com/SEC+Filings/Form++F-6EF++++++Sartorius+Stedim+Biotech+++++++++++++++Filed+by%3A+BANK+OF+NEW+YORK++ADR+DIVISION/26351097.html Wed, 22 Apr 2026 16:00:00 -0400 DIM O.00324940 SDMHF http://www.streetinsider.com/SEC+Filings/Form++F-6EF++++++Sartorius+Stedim+Biotech+++++++++++++++Filed+by%3A+BANK+OF+NEW+YORK++ADR+DIVISION/26351097.html si-local-file:///var/storage/secattach/20260422/26351097.html http://www.streetinsider.com/SEC+Filings/Form++F-6EF++++++Sartorius+Stedim+Biotech+++++++++++++++Filed+by%3A+BANK+OF+NEW+YORK++ADR+DIVISION/26351097.html Wed, 22 Apr 2026 16:00:00 -0400 DIM O.00324940 SDMHF http://www.streetinsider.com/SEC+Filings/Form++F-6EF++++++Sartorius+Stedim+Biotech+++++++++++++++Filed+by%3A+BANK+OF+NEW+YORK++ADR+DIVISION/26351097.html si-local-file:///var/storage/secattach/20260422/26351097.html http://www.streetinsider.com/SEC+Filings/Form++F-6EF++++++Sartorius+Stedim+Biotech+++++++++++++++Filed+by%3A+BANK+OF+NEW+YORK++ADR+DIVISION/26351097.html Wed, 22 Apr 2026 16:00:00 -0400 DIM O.00324940 SDMHF http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26235782.html <p>Goldman Sachs analyst James Quigley upgraded Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) from Neutral to Buy with a price target of EUR214.00 (from EUR235.00).</p><p>The analyst comments: "Underlying drivers continue to look strong, equipment should recover in n time - we upgrade Stedim to Buy and remain Neutral on Sartorius Group, reflecting a widening of the spread. While some of the initiatives highlighted at the CMD may take some time to come through (single use continuous/process intensification, biosimilar uptake in single use systems), management laid out the key drivers supporting the expected 7-9% market growth across its key areas. These remain http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26235782.html Mon, 30 Mar 2026 03:32:36 -0400 SDMHF http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26235782.html <p>Goldman Sachs analyst James Quigley upgraded Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) from Neutral to Buy with a price target of EUR214.00 (from EUR235.00).</p><p>The analyst comments: "Underlying drivers continue to look strong, equipment should recover in n time - we upgrade Stedim to Buy and remain Neutral on Sartorius Group, reflecting a widening of the spread. While some of the initiatives highlighted at the CMD may take some time to come through (single use continuous/process intensification, biosimilar uptake in single use systems), management laid out the key drivers supporting the expected 7-9% market growth across its key areas. These remain http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26235782.html Mon, 30 Mar 2026 03:32:36 -0400 SDMHF http://www.streetinsider.com/Upgrades/Goldman+Sachs+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26235782.html <p>Goldman Sachs analyst James Quigley upgraded Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) from Neutral to Buy with a price target of EUR214.00 (from EUR235.00).</p><p>The analyst comments: "Underlying drivers continue to look strong, equipment should recover in n time - we upgrade Stedim to Buy and remain Neutral on Sartorius Group, reflecting a widening of the spread. While some of the initiatives highlighted at the CMD may take some time to come through (single use continuous/process intensification, biosimilar uptake in single use systems), management laid out the key drivers supporting the expected 7-9% market growth across its key areas. These remain http://www.streetinsider.com/Upgrades/Goldman+Sachs+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26235782.html Mon, 30 Mar 2026 03:32:36 -0400 SDMHF http://www.streetinsider.com/Upgrades/Goldman+Sachs+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26235782.html <p>Goldman Sachs analyst James Quigley upgraded Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) from Neutral to Buy with a price target of EUR214.00 (from EUR235.00).</p><p>The analyst comments: "Underlying drivers continue to look strong, equipment should recover in n time - we upgrade Stedim to Buy and remain Neutral on Sartorius Group, reflecting a widening of the spread. While some of the initiatives highlighted at the CMD may take some time to come through (single use continuous/process intensification, biosimilar uptake in single use systems), management laid out the key drivers supporting the expected 7-9% market growth across its key areas. These remain http://www.streetinsider.com/Upgrades/Goldman+Sachs+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26235782.html Mon, 30 Mar 2026 03:32:36 -0400 SDMHF http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26235782.html <p>Goldman Sachs analyst James Quigley upgraded Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) from Neutral to Buy with a price target of EUR214.00 (from EUR235.00).</p><p>The analyst comments: "Underlying drivers continue to look strong, equipment should recover in n time - we upgrade Stedim to Buy and remain Neutral on Sartorius Group, reflecting a widening of the spread. While some of the initiatives highlighted at the CMD may take some time to come through (single use continuous/process intensification, biosimilar uptake in single use systems), management laid out the key drivers supporting the expected 7-9% market growth across its key areas. These remain http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26235782.html Mon, 30 Mar 2026 03:32:36 -0400 SDMHF http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26235782.html <p>Goldman Sachs analyst James Quigley upgraded Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) from Neutral to Buy with a price target of EUR214.00 (from EUR235.00).</p><p>The analyst comments: "Underlying drivers continue to look strong, equipment should recover in n time - we upgrade Stedim to Buy and remain Neutral on Sartorius Group, reflecting a widening of the spread. While some of the initiatives highlighted at the CMD may take some time to come through (single use continuous/process intensification, biosimilar uptake in single use systems), management laid out the key drivers supporting the expected 7-9% market growth across its key areas. These remain http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26235782.html Mon, 30 Mar 2026 03:32:36 -0400 SDMHF http://www.streetinsider.com/SEC+Filings/Form++F-6EF++++++Sartorius+Stedim+Biotech+++++++++++++++Filed+by%3A+JPMorgan+Chase+Bank%2C+N.A.+-+ADR+Depositary/26202296.html si-local-file:///var/storage/secattach/20260323/26202296.html http://www.streetinsider.com/SEC+Filings/Form++F-6EF++++++Sartorius+Stedim+Biotech+++++++++++++++Filed+by%3A+JPMorgan+Chase+Bank%2C+N.A.+-+ADR+Depositary/26202296.html Mon, 23 Mar 2026 11:34:00 -0400 DIM O.00324940 SDMHF http://www.streetinsider.com/SEC+Filings/Form++F-6EF++++++Sartorius+Stedim+Biotech+++++++++++++++Filed+by%3A+JPMorgan+Chase+Bank%2C+N.A.+-+ADR+Depositary/26202296.html si-local-file:///var/storage/secattach/20260323/26202296.html http://www.streetinsider.com/SEC+Filings/Form++F-6EF++++++Sartorius+Stedim+Biotech+++++++++++++++Filed+by%3A+JPMorgan+Chase+Bank%2C+N.A.+-+ADR+Depositary/26202296.html Mon, 23 Mar 2026 11:34:00 -0400 DIM O.00324940 SDMHF http://www.streetinsider.com/SEC+Filings/Form++F-6EF++++++Sartorius+Stedim+Biotech+++++++++++++++Filed+by%3A+JPMorgan+Chase+Bank%2C+N.A.+-+ADR+Depositary/26202296.html si-local-file:///var/storage/secattach/20260323/26202296.html http://www.streetinsider.com/SEC+Filings/Form++F-6EF++++++Sartorius+Stedim+Biotech+++++++++++++++Filed+by%3A+JPMorgan+Chase+Bank%2C+N.A.+-+ADR+Depositary/26202296.html Mon, 23 Mar 2026 11:34:00 -0400 DIM O.00324940 SDMHF http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR220+at+Barclays/26194964.html Barclays analyst Charles Pitman lowered the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR220.00 (from EUR230.00) while maintaining a Overweight rating. http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR220+at+Barclays/26194964.html Fri, 20 Mar 2026 06:45:13 -0400 SDMHF http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR220+at+Barclays/26194964.html Barclays analyst Charles Pitman lowered the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR220.00 (from EUR230.00) while maintaining a Overweight rating. http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR220+at+Barclays/26194964.html Fri, 20 Mar 2026 06:45:13 -0400 SDMHF http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR220+at+Barclays/26194964.html Barclays analyst Charles Pitman lowered the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR220.00 (from EUR230.00) while maintaining a Overweight rating. http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR220+at+Barclays/26194964.html Fri, 20 Mar 2026 06:45:13 -0400 SDMHF http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR220+at+Barclays/26194964.html Barclays analyst Charles Pitman lowered the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR220.00 (from EUR230.00) while maintaining a Overweight rating. http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Lowered+to+EUR220+at+Barclays/26194964.html Fri, 20 Mar 2026 06:45:13 -0400 SDMHF http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR262+at+Jefferies/26178098.html Jefferies analyst James Vane-Tempest raised the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR262.00 (from EUR256.00) while maintaining a Buy rating. http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR262+at+Jefferies/26178098.html Wed, 18 Mar 2026 05:40:57 -0400 SDMHF http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR262+at+Jefferies/26178098.html Jefferies analyst James Vane-Tempest raised the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR262.00 (from EUR256.00) while maintaining a Buy rating. http://www.streetinsider.com/Intl+Ratings/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR262+at+Jefferies/26178098.html Wed, 18 Mar 2026 05:40:57 -0400 SDMHF http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR262+at+Jefferies/26178098.html Jefferies analyst James Vane-Tempest raised the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR262.00 (from EUR256.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR262+at+Jefferies/26178098.html Wed, 18 Mar 2026 05:40:57 -0400 SDMHF http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR262+at+Jefferies/26178098.html Jefferies analyst James Vane-Tempest raised the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR262.00 (from EUR256.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+PT+Raised+to+EUR262+at+Jefferies/26178098.html Wed, 18 Mar 2026 05:40:57 -0400 SDMHF http://www.streetinsider.com/Intl+Ratings/Kepler+Cheuvreux+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26177989.html <p>Kepler Cheuvreux analyst Oliver Reinberg upgraded Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) from Hold to Buy with a price target of EUR225.00 (from EUR210.00).</p> http://www.streetinsider.com/Intl+Ratings/Kepler+Cheuvreux+Upgrades+Sartorius+Stedim+Biotech+%28DIM%3AFP%29+%28SDMHF%29+to+Buy/26177989.html Wed, 18 Mar 2026 04:09:47 -0400 SDMHF